Literature DB >> 7703526

Glycolysis and growth rate in normal and in hexokinase-transfected NIH-3T3 cells.

M Fanciulli1, M G Paggi, T Bruno, C Del Carlo, F Bonetto, F P Gentile, A Floridi.   

Abstract

The glycolytic enzyme hexokinase plays a key role in regulating cell energy metabolism. Its activity has been associated with cell growth rate and, notably, with neoplastic transformation. NIH-3T3 cells were transfected with a tumor hexokinase cDNA. The transfected cells showed increased hexokinase amount and activity, mainly located in the particulate cellular fraction, increased glycolytic rate evaluated as lactate production, and, finally, enhanced growth rate. These data may suggest that high hexokinase activity might be not merely the consequence of peculiar metabolic demands by actively replicating normal or cancer cells, but also a modification able per se to drive, at least partially, a more intense mitotic activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7703526

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  7 in total

Review 1.  The voltage-dependent anion channel in endoplasmic/sarcoplasmic reticulum: characterization, modulation and possible function.

Authors:  V Shoshan-Barmatz; A Israelson
Journal:  J Membr Biol       Date:  2005-03       Impact factor: 1.843

Review 2.  Uncovering the role of VDAC in the regulation of cell life and death.

Authors:  Varda Shoshan-Barmatz; Nurit Keinan; Hilal Zaid
Journal:  J Bioenerg Biomembr       Date:  2008-06       Impact factor: 2.945

Review 3.  The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy.

Authors:  S Mazurek; C B Boschek; E Eigenbrodt
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

4.  In self-defence: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death.

Authors:  Heftsi Azoulay-Zohar; Adrian Israelson; Salah Abu-Hamad; Varda Shoshan-Barmatz
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

5.  VDAC1: from structure to cancer therapy.

Authors:  Varda Shoshan-Barmatz; Dario Mizrachi
Journal:  Front Oncol       Date:  2012-11-29       Impact factor: 6.244

6.  Ca2+-induced changes in energy metabolism and viability of melanoma cells.

Authors:  L Glass-Marmor; J Penso; R Beitner
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

7.  High glycolysis in gliomas despite low hexokinase transcription and activity correlated to chromosome 10 loss.

Authors:  S Oudard; F Arvelo; L Miccoli; F Apiou; A M Dutrillaux; M Poisson; B Dutrillaux; M F Poupon
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.